Kp Tissue, Inc. · TSX:KPT
Kp Tissue — Q1 2026 Earnings Presentation
11 slides from Kp Tissue's earnings presentation, May 14, 2026
Slide 1: KP Tissue Releases First Quarter 2026 Financial Results
NEWS RELEASE For immediate release KP Tissue Releases First Quarter 2026 Financial Results Strong profitability amid a volatile economic environment Mississauga (ON), May 14, 2026 - KP Tissue Inc. (KPT) (TSX: KPT) reports the Q1 2026 financial and operational results of KPT and Kruger Products Inc.
Slide 2: Selling, general and administrative expenses
Selling, general and administrative (SG&A) expenses were $51.2 million in both Q1 2026 and Q1 2025. Additional investment in our brands and IT was essentially offset by lower compensation related costs and foreign exchange gains in Q1 2026 compared to losses in Q1 2025. As a percentage of revenue, S
Slide 3: About Kruger Products Inc.
About Kruger Products Inc. Kruger Products is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. Kruger Products serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterr
Slide 4: Forward-Looking Statements
brands; Kruger Products’ sales being less than anticipated; Kruger Products’ failure to implement its business and operating strategies; Kruger Products’ obligation to make regular capital expenditures; Kruger Products entering into unsuccessful acquisitions; Kruger Products’ dependence on key perso
Slide 5: Kruger Products Inc. Unaudited Condensed Consolidated Statements of Financial Position
Kruger Products Inc. Unaudited Condensed Consolidated Statements of Financial Position (thousands of Canadian dollars) March 31, 2026 December 31, 2025 $ $ Assets Current assets Cash and cash equivalents 205,913 196,094 Restricted cash 48,186 46,070 Trade and other receivables 129,499 143,313 Receiv
Slide 6: Kruger Products Inc. Unaudited Condensed Consolidated Statements Income
Kruger Products Inc. Unaudited Condensed Consolidated Statements Income (thousands of Canadian dollars) 3-month 3-month period ended period ended March 31, 2026 March 31, 2025 $ $ Revenue 544,646 546,110 Expenses Cost of sales 436,873 450,983 Selling, general and administrative expenses 51,235 51,21
Slide 7: Kruger Products Inc. Unaudited Condensed Consolidated Statements of Cash Flows
Kruger Products Inc. Unaudited Condensed Consolidated Statements of Cash Flows (thousands of Canadian dollars) 3-month 3-month period ended period ended March 31, 2026 March 31, 2025 $ $ Cash flows from (used in) operating activities Net income including non-controlling interest 21,007 16,879 Items
Slide 8: Kruger Products Inc. Unaudited Segment and Geographic Results
Kruger Products Inc. Unaudited Segment and Geographic Results (thousands of Canadian dollars) 3-month 3-month period ended period ended March 31, 2026 March 31, 2025 $ $ Segment Information Segment Revenue Consumer 461,728 465,190 AFH 82,918 80,920 Revenue from external customers 544,646 546,110 Oth
Slide 9: KP Tissue Inc. Unaudited Condensed Statements of Financial Position
KP Tissue Inc. Unaudited Condensed Statements of Financial Position (thousands of Canadian dollars) March 31, 2026 December 31, 2025 $ $ Assets Current assets Dividends receivable 1,804 1,803 1,804 1,803 Non-current assets Investment in associate 71,080 69,799 Total assets 72,884 71,602 Liabilities
Slide 10: KP Tissue Inc. Unaudited Condensed Statements of Income
KP Tissue Inc. Unaudited Condensed Statements of Income (thousands of Canadian dollars, except share and per share amounts) 3-month 3-month period ended period ended March 31, 2026 March 31, 2025 $ $ Share of income 2,390 1,917 Depreciation of fair value increments (270) (284) Equity income 2,120 1,
Slide 11: KP Tissue Inc. Unaudited Statements of Cash Flows
KP Tissue Inc. Unaudited Statements of Cash Flows (thousands of Canadian dollars) 3-month 3-month period ended period ended March 31, 2026 March 31, 2025 $ $ Cash flows from (used in) operating activities Net income (loss) 2,179 1,747 Items not affecting cash Equity income (loss) (2,120) (1,633) Dil